Vault-13

FRAZIER MANAGEMENT LLC

SEATTLE, WA · CIK 1032165 · 13F filing filed 2022-02-08

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

As an employer

US visa salary filings

Job titleFilingsMedianRange
Associate, Investment AnalystSeattle, WA 1 $125,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Frazier Management LLC.

$1.3bn reported value +3.9% vs Q3 2021
43positions
55.9%in top 10
6 new 12 added 2 reduced 4 sold out vs Q3 2021

Holdings, Q4 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 8,434,232 $174.9m13.47% 13.47% UnchangedShares held: Q1 2021 10.5m, Q2 2021 8.4m, Q3 2021 8.4m, Q4 2021 8.4m
2 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 5,827,415 $114.6m8.82% 8.82% UnchangedShares held: Q1 2021 5.8m, Q2 2021 5.8m, Q3 2021 5.8m, Q4 2021 5.8m
3 IMAGO BIOSCIENCES INC COM COM 2,971,274 $70.4m5.42% 5.42% UnchangedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 3.0m, Q4 2021 3.0m
4 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 2,772,062 $60.7m4.67% 4.67% AddedShares held: Q1 2021 1.4m, Q2 2021 1.2m, Q3 2021 1.2m, Q4 2021 2.8m +1.6m +1,583,927 133.3%
5 GRITSTONE BIO INC COM GRTS GRTS 4,667,242 $60.0m4.62% 4.62% UnchangedShares held: Q1 2021 1.0m, Q2 2021 1.0m, Q3 2021 4.7m, Q4 2021 4.7m
6 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 3,566,912 $56.9m4.38% 4.38% UnchangedShares held: Q1 2021 3.6m, Q2 2021 3.6m, Q3 2021 3.6m, Q4 2021 3.6m
7 VAXCYTE INC COM PCVX PCVX 2,309,554 $54.9m4.23% 4.23% UnchangedShares held: Q1 2021 2.3m, Q2 2021 2.3m, Q3 2021 2.3m, Q4 2021 2.3m
8 KRYSTAL BIOTECH INC COM KRYS KRYS 771,250 $53.9m4.15% 4.15% UnchangedShares held: Q1 2021 895.0k, Q2 2021 787.9k, Q3 2021 771.2k, Q4 2021 771.2k
9 PARDES BIOSCIENCES INC COM COM 2,457,507 $40.2m3.10% 3.10% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 2.5m
10 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,384,293 $39.3m3.03% 3.03% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 851.3k, Q4 2021 1.4m +533.0k +532,987 62.6%
11 CHINOOK THERAPEUTICS INC COM ADRO ADRO 2,371,918 $38.7m2.98% 2.98% AddedShares held: Q1 2021 0, Q2 2021 1.1m, Q3 2021 1.7m, Q4 2021 2.4m +700.0k +700,000 41.9%
12 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 555,240 $33.8m2.60% 2.60% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 442.9k, Q4 2021 555.2k +112.4k +112,360 25.4%
13 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 1,747,622 $33.4m2.57% 2.57% ReducedShares held: Q1 2021 1.3m, Q2 2021 2.1m, Q3 2021 2.7m, Q4 2021 1.7m -926.7k -926,677 -34.6%
14 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,417,157 $31.9m2.45% 2.45% UnchangedShares held: Q1 2021 1.9m, Q2 2021 1.4m, Q3 2021 1.4m, Q4 2021 1.4m
15 PASSAGE BIO INC COM COM 5,009,219 $31.8m2.45% 2.45% UnchangedShares held: Q1 2021 5.0m, Q2 2021 5.0m, Q3 2021 5.0m, Q4 2021 5.0m
16 ANAPTYSBIO INC COM ANAB ANAB 899,700 $31.3m2.41% 2.41% UnchangedShares held: Q1 2021 899.7k, Q2 2021 899.7k, Q3 2021 899.7k, Q4 2021 899.7k
17 IVERIC BIO INC COM OPHT OPHT 1,838,402 $30.7m2.37% 2.37% UnchangedShares held: Q1 2021 2.5m, Q2 2021 2.5m, Q3 2021 1.8m, Q4 2021 1.8m
18 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,505,200 $29.8m2.29% 2.29% UnchangedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 1.5m, Q4 2021 1.5m
19 SIERRA ONCOLOGY INC COM NEW COM NEW 1,264,861 $27.5m2.12% 2.12% AddedShares held: Q1 2021 202.8k, Q2 2021 202.8k, Q3 2021 804.7k, Q4 2021 1.3m +460.2k +460,194 57.2%
20 SUTRO BIOPHARMA INC COM COM 1,776,479 $26.4m2.04% 2.04% AddedShares held: Q1 2021 1.0m, Q2 2021 1.0m, Q3 2021 1.5m, Q4 2021 1.8m +307.8k +307,816 21.0%
21 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 1,784,913 $24.7m1.90% 1.90% AddedShares held: Q1 2021 2.6m, Q2 2021 2.6m, Q3 2021 1.8m, Q4 2021 1.8m +13.1k +13,069 0.7%
22 SILENCE THERAPEUTICS PLC ADS SLN SLN 886,173 $21.2m1.63% 1.63% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 886.2k
23 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 3,746,857 $19.4m1.50% 1.50% AddedShares held: Q1 2021 0, Q2 2021 2.3m, Q3 2021 3.5m, Q4 2021 3.7m +216.2k +216,200 6.1%
24 MERUS N V COM MRUS MRUS 559,179 $17.8m1.37% 1.37% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 559.2k
25 REPLIMUNE GROUP INC COM REPL REPL 650,862 $17.6m1.36% 1.36% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 492.0k, Q4 2021 650.9k +158.9k +158,864 32.3%
26 TYRA BIOSCIENCES INC COM TYRA TYRA 1,250,000 $17.6m1.35% 1.35% UnchangedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 1.2m, Q4 2021 1.2m
27 KALVISTA PHARMACEUTICALS INC COM KALV KALV 1,305,087 $17.3m1.33% 1.33% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 156.8k, Q4 2021 1.3m +1.1m +1,148,280 732.3%
28 TRICIDA INC COM TCDA TCDA 1,783,893 $17.1m1.31% 1.31% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 1.8m
29 COGENT BIOSCIENCES INC COM COGT COGT 1,774,891 $15.2m1.17% 1.17% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 1.8m
30 FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 UNIT 12/09/2025 1,501,000 $14.9m1.15% 1.15% UnchangedShares held: Q1 2021 1.5m, Q2 2021 1.5m, Q3 2021 1.5m, Q4 2021 1.5m
31 ARVINAS INC COM ARVN ARVN 163,763 $13.5m1.04% 1.04% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 163.8k
32 GRACELL BIOTECHNOLOGIES INC SPONSORED ADS SPONSORED ADS 1,654,938 $10.0m0.77% 0.77% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 851.6k, Q4 2021 1.7m +803.3k +803,300 94.3%
33 ESSA PHARMA INC COM NEW EPI EPI 543,470 $7.7m0.59% 0.59% AddedShares held: Q1 2021 316.6k, Q2 2021 316.6k, Q3 2021 358.3k, Q4 2021 543.5k +185.1k +185,124 51.7%
34 REGENXBIO INC COM RGNX RGNX 235,809 $7.7m0.59% 0.59% UnchangedShares held: Q1 2021 352.0k, Q2 2021 352.0k, Q3 2021 235.8k, Q4 2021 235.8k
35 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 951,814 $7.7m0.59% 0.59% UnchangedShares held: Q1 2021 578.1k, Q2 2021 578.1k, Q3 2021 951.8k, Q4 2021 951.8k
36 ACLARIS THERAPEUTICS INC COM ACRS ACRS 408,329 $5.9m0.46% 0.46% UnchangedShares held: Q1 2021 696.0k, Q2 2021 370.7k, Q3 2021 408.3k, Q4 2021 408.3k
37 MOLECULAR TEMPLATES INC COM COM 1,374,047 $5.4m0.41% 0.41% UnchangedShares held: Q1 2021 1.4m, Q2 2021 1.4m, Q3 2021 1.4m, Q4 2021 1.4m
38 APTINYX INC COM COM 1,883,244 $5.0m0.39% 0.39% UnchangedShares held: Q1 2021 3.2m, Q2 2021 1.9m, Q3 2021 1.9m, Q4 2021 1.9m
39 IMMUNOVANT INC COM IMVT IMVT 585,759 $5.0m0.38% 0.38% UnchangedShares held: Q1 2021 508.0k, Q2 2021 254.0k, Q3 2021 585.8k, Q4 2021 585.8k
40 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 156,000 $3.9m0.30% 0.30% UnchangedShares held: Q1 2021 156.0k, Q2 2021 156.0k, Q3 2021 156.0k, Q4 2021 156.0k
41 EPIZYME INC COM EPZM EPZM 739,369 $1.8m0.14% 0.14% UnchangedShares held: Q1 2021 739.4k, Q2 2021 739.4k, Q3 2021 739.4k, Q4 2021 739.4k
42 ALLENA PHARMACEUTICALS COM ALNA ALNA 1,651,357 $978.0k0.08% 0.08% ReducedShares held: Q1 2021 3.3m, Q2 2021 3.3m, Q3 2021 3.3m, Q4 2021 1.7m -1.7m -1,679,016 -50.4%
43 NABRIVA THERAPEUTICS PLC SHS SHS 425,650 $255.0k0.02% 0.02% UnchangedShares held: Q1 2021 425.6k, Q2 2021 425.6k, Q3 2021 425.6k, Q4 2021 425.6k

Sold out since Q3 2021

SecurityTickerShares held beforeValue then
TRILLIUM THERAPEUTICS INC TR TR 3,123,107 $55.0m3.1m shares
BELLUS HEALTH INC NEW BLU BLU 433,247 $2.6m433.2k shares
GALERA THERAPEUTICS INC 241,000 $2.0m241.0k shares
FREELINE THERAPEUTICS HLDGS 550,000 $1.9m550.0k shares